Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vedat Hamuryudan

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|January 8, 2021
Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled StudySinem Nihal Esatoglu, Fatma Nihan Akkoc-Mustafayev, Yesim Ozguler, et al.
Rheumatology International|April 4, 2022
Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccineAyse Ozdede, Sabriye Guner, Guzin Ozcifci, et al.
Clinical Immunology (Orlando, Fla.)|June 29, 2023
Infliximab for vascular involvement in Behçet's syndromeGulen Hatemi, Nur Beyza Tukek, Sinem Nihal Esatoglu, et al.
Archives of Osteoporosis|August 30, 2020
Updated approach for the management of osteoporosis in Turkey: a consensus reportYeşim Kirazlı, Funda Atamaz Çalış, Özlem El, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Rheumatology (Oxford, England)|August 7, 2024
De novo manifestations during adalimumab treatment in Behçet's syndromeSinem Nihal Esatoglu, Ozge Sonmez, Didar Ucar, et al.
Rheumatology International|July 6, 2021
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination ratesAysa Hacioglu, Sermin Borekci, Melike Melikoglu, et al.
Rheumatology (Oxford, England)|December 27, 2021
Emergence of new manifestations during infliximab treatment in Behçet's syndromeNur Beyza Tukek, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Clinical and Experimental Rheumatology|May 2, 2012
The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in TurkeySimten Malhan, Salih Pay, Sebnem Ataman, et al.
Clinical and Experimental Rheumatology|July 20, 2023
Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for RheumatologyDuygu Temiz Karadag, Yasemin Yalcinkaya, Ali Akdogan, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|January 8, 2021
Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled StudySinem Nihal Esatoglu, Fatma Nihan Akkoc-Mustafayev, Yesim Ozguler, et al.
Rheumatology International|April 4, 2022
Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccineAyse Ozdede, Sabriye Guner, Guzin Ozcifci, et al.
Clinical Immunology (Orlando, Fla.)|June 29, 2023
Infliximab for vascular involvement in Behçet's syndromeGulen Hatemi, Nur Beyza Tukek, Sinem Nihal Esatoglu, et al.
Archives of Osteoporosis|August 30, 2020
Updated approach for the management of osteoporosis in Turkey: a consensus reportYeşim Kirazlı, Funda Atamaz Çalış, Özlem El, et al.
Clinical and Experimental Rheumatology|December 21, 2019
Biosimilar infliximab for Behçet's syndrome: a case seriesElif Dincses, Sinem Nihal Esatoglu, Yesim Ozguler, et al.
Rheumatology (Oxford, England)|August 7, 2024
De novo manifestations during adalimumab treatment in Behçet's syndromeSinem Nihal Esatoglu, Ozge Sonmez, Didar Ucar, et al.
Rheumatology International|July 6, 2021
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination ratesAysa Hacioglu, Sermin Borekci, Melike Melikoglu, et al.
Rheumatology (Oxford, England)|December 27, 2021
Emergence of new manifestations during infliximab treatment in Behçet's syndromeNur Beyza Tukek, Sinem Nihal Esatoglu, Gulen Hatemi, et al.
Clinical and Experimental Rheumatology|May 2, 2012
The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in TurkeySimten Malhan, Salih Pay, Sebnem Ataman, et al.
Clinical and Experimental Rheumatology|July 20, 2023
Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for RheumatologyDuygu Temiz Karadag, Yasemin Yalcinkaya, Ali Akdogan, et al.
Pageof 9